Stem cell transplantation from identical twins in patients with myelodysplastic syndromes

Bone Marrow Transplantation

Volumn 35, Issue 1, 2005, Pages 37-43

  Kroger N ^a   Brand, R ^b   van Biezen, A ^b   Bron, D ^c   Blaise, D ^d   Hellstrom Lindberg E ^e   Gahrton, G ^e   Powles, R ^f   Littlewood, T ^g   Chapuis, B ^h   Zander, A ^a   Koza, V ⁱ   Niederwieser, D ^j   de Witte, T ^k   Gratwohl, A ^l   Barge, R ^m   Bunjes, D ⁿ   Devergie, A ^o   Harousseau, J L ^p   Simonsson, B ^q   Reiffers, J ^r   Alessandrino, E P ^s   Hertenstein, B ^t   Kolb, H J ^u   Attal, M ^v   Vitek, A ^w   Sanz, M A ^x   Holowiecki, J ^y   Moraleda, J M ^z   Newland, A C ^aa   Finke, J ^ab   more..

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LEIDEN UNIVERSITY   (Netherlands)

^c JULES BORDET INSTITUTE   (Belgium)

^d INSTITUT PAOLI CALMETTES   (France)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f ROYAL MARSDEN HOSPITAL   (United Kingdom)

^g OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^h GENEVA UNIVERSITY HOSPITALS   (Switzerland)

ⁱ CHARLES UNIVERSITY   (Czech Republic)

^j UNIVERSITY OF LEIPZIG   (Germany)

^k RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^l UNIVERSITY HOSPITAL BASEL   (Switzerland)

^m LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ Innere Medizin C   (Germany)

^o SAINT LOUIS HOSPITAL   (France)

^p HÔTEL DIEU   (France)

^q UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^r HAUT LÉVÊQUE HOSPITAL   (France)

^s FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^t HANNOVER MEDICAL SCHOOL   (Germany)

^u LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^v CHU PURPAN   (France)

^w INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^x HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^y MEDICAL UNIVERSITY OF SILESIA   (Poland)

^z Unidad de Transplante de Medula Osea   (Spain)

^aa ROYAL LONDON HOSPITAL   (United Kingdom)

^ab UNIVERSITY OF FREIBURG   (Germany)

more..

Author keywords

Allogeneic stem cell transplantation; Myelodysplastic syndrome; Syngeneic stem cell transplantation

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CANCER RELAPSE; CONTROLLED STUDY; GRAFT SURVIVAL; HLA MATCHING; HUMAN; INCIDENCE; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MONOZYGOTIC TWINS; MORTALITY; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; MYCOSIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SCHOOL CHILD; SIBLING; STEM CELL TRANSPLANTATION; THROMBOCYTE ACTIVATION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 19944425990     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704701     Document Type: Article

References (26)

1. Greenberg P, Cox C, LeBeau MM et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-2088.
2. Anderson JE, Appelbaum FR, Fisher LD et al. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood 1993; 82: 677-681.
3. Castro-Malaspina H, Harris RE, Gajewski J et al. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program. Blood 2002; 99: 1943-1951.
4. de Witte T, Hermans J, Vossen J et al. Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 2000; 110: 620-630.
5. Longmore G, Guinan EC, Weinstein HJ et al. Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia. J Clin Oncol 1990; 8: 1707-1714.
6. Ratanatharathorn V, Karanes C, Uberti J et al. Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromes. Blood 1993; 81: 2194-2199.
7. Sierra J, Perez WS, Rozman C et al. Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. Blood 2002; 100: 1997-2004.
8. Sutton L, Chastang C, Ribaud P et al. Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Societe Francaise de Greffe de Moelle. Blood 1996; 88: 358-365.
9. Gale RP, Horowitz MM, Ash RC et al. Identical-twin bone marrow transplants for leukemia. Ann Intern Med 1994; 120: 646-652.
10. Runde V, de Witte T, Arnold R et al. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998; 21: 255-261.
11. Arnold R, de Witte T, van Biezen A et al. Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey. European Blood and Marrow Transplantation Group. Bone Marrow Transplant 1998; 21 1213-1216.
12. Appelbaum FR, Anderson J. Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score. Leukemia 1998; 12 (Suppl 1): S25-S29.
13. Nevill TJ, Fung HC, Shepherd JD et al. Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation. Blood 1998; 92: 1910-1917.
14. Collins Jr RH, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15 433-444.
15. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 1995; 86: 2041-2050.
16. Einsele H, Elninger G, Schneider EM et al. High frequency of graft-versus-host-like syndromes following syngeneic bone marrow transplantation. Transplantation 1988; 45: 579-585.
17. Hood AF, Vogelsang GB, Black LP et al. Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation. Arch Dermatol 1987; 123: 745-750.
18. Rappeport J, Mihm M, Reinherz; E et al. Acute graft-versus-host disease in recipients of bone-marrow transplants from identical twin donors. Lancet 1979; 2: 717-720.
19. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85-86.
20. Charak BS, Agah R, Mazumder A. Synergism of interleukin-2 and cyclosporine A in induction of a graft-versus-tumor effect without graft-versus-host disease after syngeneic bone marrow transplantation. Blood 1992; 80: 179-184.
21. Fefer A, Cheever MA, Thomas ED et al. Bone marrow transplantation for refractory acute leukemia in 34 patients with identical twins. Blood 1981; 57: 421-430.
22. Deeg HJ, Shulman HM, Anderson JE et al. Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age. Blood 2000; 95: 1188-1194.
23. Guardiola P, Runde V, Bacigalupo A et al. Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes. Blood 2002; 99: 4370-4378.
24. Barrett AJ, Ringden O, Zhang MJ et al. Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. Blood 2000; 95: 3323-3327.
25. Fefer A, Cheever MA, Greenberg PD et al. Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins. N Engl J Med 1982; 306: 63-68.
26. Gahrton G, Svensson H, Bjorkstrand B et al. Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1999; 24: 741-745.